Progressive Meningiomas

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas with SMO/ AKT/ NF2/CDK Pathway Mutations

Schedule an Appointment

Select an appointment date and time from available spots listed below.